HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lu, J. Articles by Danielsen, M. Search for Related Content PubMed PubMed Citation Articles by Lu, J. Articles by Danielsen, M. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 47, 31528-31533, November 20, 1998

Differential Regulation of Androgen and Glucocorticoid Receptors by Retinoblastoma Protein

From the Department of Biochemistry and Molecular Biology, Georgetown University Medical School, Washington, D. C. 20007

The androgen receptor (AR) plays a major role in the development and maintenance of male primary and secondary sexual characteristics. The growth promoting effects of androgens are clearly seen in prostate cancer where treatment by androgen ablation usually leads to tumor regression, followed sometime later, by growth of tumor cells that are resistant to endocrine therapy. We have found that the level of pRB in cells controls AR activity. Overexpression of pRB leads to increased transcriptional activity of the AR. This is similar to the previously reported potentiation of glucocorticoid receptor activity by pRB. In contrast, loss of pRB activity inhibits AR but not glucocorticoid receptor activity. This inhibition correlates with the unique ability of the AR to form a protein-protein complex with pRB in vitro. The site of interaction with pRB lies within the N-terminal domain of the AR and co-localizes with the region of the AR that specifies a requirement for pRB. Thus, the AR has a novel requirement for pRB raising the possibility that the growth promoting activity of AR is due to its direct interaction with pRB. Furthermore, loss of pRB activity during progression of prostate cancer may directly result in a decreased response to androgens.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				H. V. Heemers and D. J. Tindall Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex Endocr. Rev., December 1, 2007; 28(7): 778 - 808. [Abstract] [Full Text] [PDF]

				X. Yuan, T. Li, H. Wang, T. Zhang, M. Barua, R. A. Borgesi, G. J. Bubley, M. L. Lu, and S. P. Balk Androgen Receptor Remains Critical for Cell-Cycle Progression in Androgen-Independent CWR22 Prostate Cancer Cells Am. J. Pathol., August 1, 2006; 169(2): 682 - 696. [Abstract] [Full Text] [PDF]

				E. Batsche, J. Desroches, S. Bilodeau, Y. Gauthier, and J. Drouin Rb Enhances p160/SRC Coactivator-dependent Activity of Nuclear Receptors and Hormone Responsiveness J. Biol. Chem., May 20, 2005; 280(20): 19746 - 19756. [Abstract] [Full Text] [PDF]

				G. Huang and C. J. Elferink Multiple Mechanisms Are Involved in Ah Receptor-Mediated Cell Cycle Arrest Mol. Pharmacol., January 1, 2005; 67(1): 88 - 96. [Abstract] [Full Text] [PDF]

				S. Barnes-Ellerbe, K. E. Knudsen, and A. Puga 2,3,7,8-Tetrachlorodibenzo-p-dioxin Blocks Androgen-Dependent Cell Proliferation of LNCaP Cells through Modulation of pRB Phosphorylation Mol. Pharmacol., September 1, 2004; 66(3): 502 - 511. [Abstract] [Full Text] [PDF]

				C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF]

				X. Wang, H. Deng, I. Basu, and L. Zhu Induction of Androgen Receptor-Dependent Apoptosis in Prostate Cancer Cells by the Retinoblastoma Protein Cancer Res., February 15, 2004; 64(4): 1377 - 1385. [Abstract] [Full Text] [PDF]

				H.-L. Fang, S. Shenoy, Z. Duanmu, T. A. Kocarek, and M. Runge-Morris TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION Drug Metab. Dispos., November 1, 2003; 31(11): 1378 - 1381. [Abstract] [Full Text] [PDF]

				H. Pizzi, J. Gladu, L. Carpio, D. Miao, D. Goltzman, and S. A. Rabbani Androgen Regulation of Parathyroid Hormone-Related Peptide Production in Human Prostate Cancer Cells Endocrinology, March 1, 2003; 144(3): 858 - 867. [Abstract] [Full Text] [PDF]

				E. D. Martinez and M. Danielsen Loss of Androgen Receptor Transcriptional Activity at the G1/S Transition J. Biol. Chem., August 9, 2002; 277(33): 29719 - 29729. [Abstract] [Full Text] [PDF]

				C. A. Heinlein and C. Chang Androgen Receptor (AR) Coregulators: An Overview Endocr. Rev., April 1, 2002; 23(2): 175 - 200. [Abstract] [Full Text] [PDF]

				M. Stanbrough, I. Leav, P. W. L. Kwan, G. J. Bubley, and S. P. Balk Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium PNAS, September 4, 2001; (2001) 191235898. [Abstract] [Full Text] [PDF]

				I. Bieche, B. Parfait, S. Tozlu, R. Lidereau, and M. Vidaud Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene Carcinogenesis, September 1, 2001; 22(9): 1521 - 1526. [Abstract] [Full Text] [PDF]

				R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine, et al. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors Drug Metab. Dispos., April 13, 2001; 29(5): 623 - 633. [Abstract] [Full Text]

				C. J. Elferink, N.-L. Ge, and A. Levine Maximal Aryl Hydrocarbon Receptor Activity Depends on an Interaction with the Retinoblastoma Protein Mol. Pharmacol., April 1, 2001; 59(4): 664 - 673. [Abstract] [Full Text]

				J. M. Grad, L. S. Lyons, D. M. Robins, and K. L. Burnstein The Androgen Receptor (AR) Amino-Terminus Imposes Androgen-Specific Regulation of AR Gene Expression via an Exonic Enhancer Endocrinology, March 1, 2001; 142(3): 1107 - 1116. [Abstract] [Full Text] [PDF]

				H. A. Hirsch, L. Gu, and R. W. Henry The Retinoblastoma Tumor Suppressor Protein Targets Distinct General Transcription Factors To Regulate RNA Polymerase III Gene Expression Mol. Cell. Biol., December 15, 2000; 20(24): 9182 - 9191. [Abstract] [Full Text]

				J. M. Grad, J. Le Dai, S. Wu, and K. L. Burnstein Multiple Androgen Response Elements and a Myc Consensus Site in the Androgen Receptor (AR) Coding Region Are Involved in Androgen-Mediated Up-Regulation of AR Messenger RNA Mol. Endocrinol., November 1, 1999; 13(11): 1896 - 1911. [Abstract] [Full Text]

				Y.-M. Ning and D. M. Robins AML3/CBFalpha 1 Is Required for Androgen-specific Activation of the Enhancer of the Mouse Sex-limited Protein (Slp) Gene J. Biol. Chem., October 22, 1999; 274(43): 30624 - 30630. [Abstract] [Full Text] [PDF]

				P. Singh, S. W. Chan, and W. Hong Retinoblastoma Protein Is Functionally Distinct from Its Homologues in Affecting Glucocorticoid Receptor-mediated Transcription and Apoptosis J. Biol. Chem., April 20, 2001; 276(17): 13762 - 13770. [Abstract] [Full Text] [PDF]

				C. E. Petre, Y. B. Wetherill, M. Danielsen, and K. E. Knudsen Cyclin D1: Mechanism and Consequence of Androgen Receptor Co-repressor Activity J. Biol. Chem., January 11, 2002; 277(3): 2207 - 2215. [Abstract] [Full Text] [PDF]

				M. Stanbrough, I. Leav, P. W. L. Kwan, G. J. Bubley, and S. P. Balk Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium PNAS, September 11, 2001; 98(19): 10823 - 10828. [Abstract] [Full Text] [PDF]